Osteoporosis
Osteoporosis is a common age-related skeletal disorder that affects women more often than men. It leads to a reduction in bone mineral density (BMD) and deterioration of bone microstructure due to an imbalance between bone formation by osteoblasts and bone resorption by osteoclasts. With aging, the population and function of mesenchymal stem cells (MSCs) in bone marrow decline, which limits their natural role in supporting bone formation.
This condition is particularly important because of its effect on bone fragility, which can increase the risk of fractures, cause back pain, and reduce quality of life. Osteoporosis also carries a significant economic burden, highlighting the need for awareness, prevention, and education about bone health.
Current approaches to managing osteoporosis generally involve medications that reduce bone resorption by targeting osteoclast activity. While these treatments can be effective, they may sometimes cause side effects and do not always fully meet patient expectations.
In recent years, research has explored innovative methods, such as the use of stem cells, to better understand bone regeneration. Mesenchymal stem cells (MSCs) are the most widely studied in this field. Experimental studies using allogeneic bone marrow-derived MSCs in animal models of glucocorticoid-induced osteoporosis have shown potential to support osteoblast activity and promote bone formation.
